Quarterly report · Q1

Period2022-04-01 → 2022-06-30
Filed2022-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥15.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥56.6bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥14.2bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.7bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥1.2bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.8bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥4.9bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.8bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥1.3bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.3bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.3bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥1.1bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥84.8bnat 2022-06-30Cons.Assets
Total assets¥83.3bnat 2022-03-31Cons.Assets
Total assets¥81.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥34.3bnat 2022-06-30Cons.Liabilities
Total liabilities¥34.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥50.5bnat 2022-06-30Cons.Net assets
Net assets / equity¥48.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥45.3bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥17.7bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥12.1bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥46.942022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥151.222021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.722021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio59.6%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio58.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio55.5%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥44m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥29m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥15m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥18m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥15m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥15m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥169m
jpcrp040300-q1r_E35791-000Animal Health Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥1.6bn
jpcrp040300-q1r_E35791-000Animal Health Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.6bn
jpcrp040300-q1r_E35791-000Animal Health Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥124m
jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥13.6bn
jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥13.6bn
jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥15.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥15.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥15m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥42m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥30m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥12m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30−¥2m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥12m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥12m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥160m
jpcrp040300-q1r_E35791-000Animal Health Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥1.4bn
jpcrp040300-q1r_E35791-000Animal Health Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.4bn
jpcrp040300-q1r_E35791-000Animal Health Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥103m
jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥14.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥14.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥12m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥1.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 325
ItemContextValueUnit
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0759
Number of shares held in own name treasury shares etcCurrentQuarterInstant2321300
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant2321300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0759
Cash and depositsPrior1YearInstant12103000000JPY
Cash and depositsCurrentQuarterInstant17691000000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant14482000000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant14824000000JPY
Short term investment securitiesPrior1YearInstant5000000000JPY
Short term investment securitiesCurrentQuarterInstant-JPY
Merchandise and finished goodsPrior1YearInstant10016000000JPY
Merchandise and finished goodsCurrentQuarterInstant10426000000JPY
Work in processPrior1YearInstant457000000JPY
Work in processCurrentQuarterInstant535000000JPY
Raw materials and suppliesPrior1YearInstant4587000000JPY
Raw materials and suppliesCurrentQuarterInstant4896000000JPY
Other caPrior1YearInstant2911000000JPY
Other caCurrentQuarterInstant3124000000JPY
Allowance for doubtful accounts caPrior1YearInstant-0JPY
Allowance for doubtful accounts caCurrentQuarterInstant-JPY
Current assetsPrior1YearInstant49557000000JPY
Current assetsCurrentQuarterInstant51497000000JPY
Property plant and equipmentPrior1YearInstant10936000000JPY
Property plant and equipmentCurrentQuarterInstant10899000000JPY
Intangible assetsPrior1YearInstant6183000000JPY
Intangible assetsCurrentQuarterInstant5677000000JPY
Investment securitiesPrior1YearInstant12223000000JPY
Investment securitiesCurrentQuarterInstant12803000000JPY
Other ioaPrior1YearInstant4414000000JPY
Other ioaCurrentQuarterInstant3904000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-17000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-17000000JPY
Investments and other assetsPrior1YearInstant16620000000JPY
Investments and other assetsCurrentQuarterInstant16690000000JPY
Noncurrent assetsPrior1YearInstant33739000000JPY
Noncurrent assetsCurrentQuarterInstant33267000000JPY
AssetsPrior1YearInstant83297000000JPY
AssetsCurrentQuarterInstant84764000000JPY
Notes and accounts payable tradePrior1YearInstant3118000000JPY
Notes and accounts payable tradeCurrentQuarterInstant4524000000JPY
Electronically recorded obligations operating clPrior1YearInstant3723000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant2755000000JPY
Short term loans payablePrior1YearInstant1723000000JPY
Short term loans payableCurrentQuarterInstant3048000000JPY
Other provision clPrior1YearInstant1188000000JPY
Other provision clCurrentQuarterInstant539000000JPY
Other clPrior1YearInstant6257000000JPY
Other clCurrentQuarterInstant7109000000JPY
Current liabilitiesPrior1YearInstant16011000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass